Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Trillium Therapeutics
Exited company

Trillium Therapeutics Inc.

Details
Region
Ontario
Industry sector
Biotechnology
Investment year
2004
Fund
Diversified Portfolio
Learn More
About the company

Trillium is a research and development company specializing in innovative therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses. These include autoimmune and inflammatory disorders, graft rejection, cancer and chronic viral diseases. TTI identifies early-stage therapeutic candidates with promising preclinical profiles and advances these towards clinical testing, with the primary objective of demonstrating safety and efficacy in humans.